Dopamine (DA) pathways have been implicated in cognitive deficits after traumatic brain injury (TBI). Both sex and the dopamine transporter (DAT) 3′ variable number of tandem repeat polymorphism have been associated with differences in DAT protein density, and DAT protein affects both presynaptic DA release, through reverse transport, and DA reuptake. Catecholamines and associated metabolites are subject to autooxidation, resulting in the formation of reactive oxygen species that may contribute to subsequent oxidative injury. The purpose of this study was to determine associations between factors that affect DAT expression and cerebrospinal fluid (CSF) DA and metabolite levels after severe TBI.
Sixty-three patients with severe TBI (Glasgow Coma Scale score ≤ 8) were evaluated. The patients' genotypes were obtained using previously banked samples of CSF, and serial CSF samples (416 samples) were used to evaluate DA and metabolite levels. High-performance liquid chromatography was used to determine CSF levels of DA, 3,4-dihydroxyphenylacetic acid (DOPAC), and homovanillic acid (HVA) during the first 5 days after injury.
Mixed-effects multivariate regression modeling revealed that patients with the DAT 10/10 genotype had higher CSF DA levels than patients with either the DAT 9/9 or DAT 9/10 genotypes (p = 0.009). Females with the DAT 10/10 genotype had higher CSF DA levels than females with the DAT 9/9 or DAT 9/10 genotypes, and sex was associated with higher DOPAC levels (p = 0.004). Inotrope administration also contributed to higher DA levels (p = 0.002).
In addition to systemic administration of DA, inherent factors such as sex and DAT genotype affect post-TBI CSF DA and DA metabolite levels, a phenomenon that may modulate susceptibility to DA-mediated oxidative injury.
Abbreviations used in this paper:CBF = cerebral blood flow; COMT = catechol-O-methyltransferase; CPP = cerebral perfusion pressure; CSF = cerebrospinal fluid; CT = computed tomography; DA = dopamine; DAT = DA transporter; DOPAC = 3,4-dihydroxy-phenylacetic acid; EVD = extraventricular drain; GCS = Glasgow Coma Scale; HPLC = high-performance liquid chromatography; HVA = homovanillic acid; ICP = intracranial pressure; MAO = monoamine oxidase; PCR = polymerase chain reaction; SEM = standard error of the mean; TBI = traumatic brain injury; VNTR = variable number tandem repeat.
Address reprint requests to: Amy K. Wagner, M.D., Department of Physical Medicine and Rehabilitation, University of Pittsburgh, 3471 Fifth Avenue, Suite No. 202, Pittsburgh, Pennsylvania 15213. email:
DonnemillerEBrenneisCWisselJScherflerCPoeweWRiccabonaG: Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPECT study using 123I-beta-CIT and 123I-IBZM. Eur J Nucl Med27:1410–14142000
GardinerSAMorrisonMFMozleyPDMozleyLHBrensingerCBilkerW: Pilot study on the effect of estrogen replacement therapy on brain dopamine transporter availability in healthy postmenopausal women. Am J Geriatr Psychiatry12:621–6302004
GerlachMXiaoAYKuhnWLehnfeldRWaldmeierPSontagKH: The central catechol-O-methyltransferase inhibitor tolcapone increases striatal hydroxyl radical production in L-DOPA/carbidopa treated rats. J Neural Transm108:189–2042001
JonssonEGNortonNGustavssonJPOrelandLOwenMJSedvallGC: A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. J Psychiatr Res34:239–2442000
KlineAEMassucciJLMarionDWDixonCE: Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact. J Neurotrauma19:415–4252002
KrauseKHDreselSHKrauseJKungHFTatschK: Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett285:107–1102000
KroppenstedtSNStoverJFUnterbergAW: Effects of dopamine on posttraumatic cerebral blood flow, brain edema, and cerebrospinal fluid glutamate and hypoxanthine concentrations. Crit Care Med28:3792–37982000
MichelhaughSKFiskerstrandCLovejoyEBannonMJQuinnJP: The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J Neurochem79:1033–10382001
NirenbergMJChanJPohorilleAVaughanRAUhlGRKuharMJ: The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens. J Neurosci17:6899–69071997
PlengerPMDixonCECastilloRMFrankowskiRFYablonSALevinHS: Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. Arch Phys Med Rehabil77:536–5401996
PortaMBareggiSRColliceMAssaelBMSelenatiACalderiniG: Homovanillic acid and 5-hydroxyindole-acetic acid in the CSF of patients after a severe head injury. II Ventricular CSF concentrations in acute brain post-traumatic syndromes. Eur Neurol13:545–5541975
SesackSRHawrylakVAMatusCGuidoMALeveyAI: Dopamine axon varicosities in the prelimbic division of the rat pre-frontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci18:2697–27081998
VechtCJvan WoerkomCATeelkenAWMinderhoudJM: Homovanillic acid and 5-hydroxyindoleacetic acid cerebrospinal fluid levels. A study with and without probenecid administration of their relationship to the state of consciousness after head injury. Arch Neurol32:792–7971975
WhyteJHartTSchusterKFlemingMPolanskyMCoslettHB: Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebo-controlled trial. Am J Phys Med Rehabil76:440–4501997
ZhangHZhaiSDLiYMChenLR: Effect of different sample pretreatment methods on the concentrations of excitatory amino acids in cerebrospinal fluid determined by high-performance liquid chromatography. J Chromotogr B Analyt Technol Biomed Life Sci784:131–1352003